SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-012576
Filing Date
2023-05-04
Accepted
2023-05-04 16:16:48
Documents
15
Period of Report
2023-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbyi20230502_8k.htm   iXBRL 8-K 25083
2 EXHIBIT 99.1 ex_512937.htm EX-99.1 121378
7 picture1.jpg GRAPHIC 12192
  Complete submission text file 0001437749-23-012576.txt   309503

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20230504.xsd EX-101.SCH 3600
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20230504_def.xml EX-101.DEF 11531
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20230504_lab.xml EX-101.LAB 15413
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20230504_pre.xml EX-101.PRE 11687
9 EXTRACTED XBRL INSTANCE DOCUMENT pbyi20230502_8k_htm.xml XML 2573
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35703 | Film No.: 23888991
SIC: 2834 Pharmaceutical Preparations